Scenarios that move IRD

Opus Genetics, Inc. - Common Stock

Scenarios that move IRD: 1 analysis, 1 positive, 0 negative.

  1. · Opus Genetics receives FDA approval for presbyopia eye drop — ▲ · impact +93 · confidence medium · horizon immediate

All scenarios · Run a scenario · Pricing